Suppr超能文献

一次性使用内镜食管静脉曲张套扎器的再处理:一项初步研究。

Reprocessing of single-use endoscopic variceal band ligation devices: a pilot study.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, United States.

Nova Biologicals, Inc., Conroe, Texas, United States.

出版信息

Endoscopy. 2017 Dec;49(12):1202-1208. doi: 10.1055/s-0043-115004. Epub 2017 Jul 28.

Abstract

The preferred management of bleeding esophageal varices includes endoscopic band ligation. Endoscopic ligation devices (ELDs) are expensive and designed for single use, limiting their uptake in developing countries. We aimed to assess the efficacy of reprocessing ELDs using terminal microbial cultures and adenosine triphosphate (ATP) testing.  ELDs were recovered after clinical use and their components (cap, handle, and cord) were subjected to reprocessing. This included manual cleaning, automated high-level disinfection (HLD), and drying with forced air. Using sterile technique, ELD components were sampled for ATP at three stages: before manual cleaning, after manual cleaning, and after HLD. Components were sent to an external laboratory for culturing. Cultures were interpreted as positive upon identification of Gram-negative bacilli.  A total of 14 clinically used ELDs were studied, and 189 ATP tests and 41 cultures were evaluated. Overall, 95 % (39/41) of components and 86 % (12/14) of ELDs were culture-negative or did not yield Gram-negative bacilli. Two components (5 %; one handle and one cord) harbored Gram-negative bacilli in quantities of 1 CFU per component. There was no apparent correlation between ATP at any juncture of reprocessing and terminal cultures.  Reprocessing of ELDs is effective, resulting in infrequent and minimal microbial contamination. Microbial culturing can be used to ensure adequacy of ELD reprocessing if pursued. Until reusable ELDs are commercially available, continued efforts to better define the adequacy and long-term effects of reprocessing ELDs are needed.

摘要

食管静脉曲张出血的首选治疗方法包括内镜套扎。内镜套扎设备(ELDs)价格昂贵且设计为一次性使用,这限制了它们在发展中国家的应用。我们旨在评估使用末端微生物培养物和三磷酸腺苷(ATP)检测对 ELD 进行再处理的效果。

ELDs 在临床使用后被回收,其部件(帽、手柄和绳索)接受再处理。这包括手动清洁、自动高水平消毒(HLD)和强制空气干燥。使用无菌技术,在三个阶段对 ELD 部件进行 ATP 采样:手动清洁前、手动清洁后和 HLD 后。部件被送到外部实验室进行培养。当鉴定出革兰氏阴性杆菌时,培养物被解释为阳性。

共研究了 14 个临床使用的 ELD,评估了 189 次 ATP 测试和 41 次培养。总体而言,95%(39/41)的部件和 86%(12/14)的 ELD 培养阴性或未产生革兰氏阴性杆菌。两个部件(5%;一个手柄和一个绳索)携带革兰氏阴性杆菌,每个部件的数量为 1 CFU。在再处理的任何阶段,ATP 与末端培养物之间似乎没有明显的相关性。

ELD 再处理是有效的,导致微生物污染的频率和程度较低。如果进行微生物培养,可以用来确保 ELD 再处理的充分性。在可重复使用的 ELD 商业化之前,需要继续努力更好地定义 ELD 再处理的充分性和长期效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验